Francy Cruz-Sanabria, Claudia Carmassi, Simone Bruno, Andrea Bazzani, Marco Carli, Marco Scarselli & Ugo Faraguna. (2023) Melatonin as a Chronobiotic with Sleep-promoting Properties. Current Neuropharmacology 21:4, pages 951-987.
Crossref
Ralph E. Mistlberger & Myriam Juda. 2023. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms
713
726
.
Rüdiger Hardeland. (2022) Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions. Antioxidants & Redox Signaling 37:10-12, pages 704-725.
Crossref
Deanna M. Minich, Melanie Henning, Catherine Darley, Mona Fahoum, Corey B. Schuler & James Frame. (2022) Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements. Nutrients 14:19, pages 3934.
Crossref
Helen J. Burgess & Jonathan S. Emens. (2022) Drugs Used in Circadian Sleep-Wake Rhythm Disturbances. Sleep Medicine Clinics 17:3, pages 421-431.
Crossref
Phillip T. Yuhas. (2022) Non-24-Hour Sleep–Wake Disorder and Tasimelteon: A Review for Practitioners Who Work With Blind People. Journal of Visual Impairment & Blindness 116:1, pages 70-84.
Crossref
Kimberly Johnson, Meghna P. Mansukhani & Bhanu Prakash Kolla. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
149
178
.
Martijn Arns, J.J. Sandra Kooij & Andrew N. Coogan. (2021) Review: Identification and Management of Circadian Rhythm Sleep Disorders as a Transdiagnostic Feature in Child and Adolescent Psychiatry. Journal of the American Academy of Child & Adolescent Psychiatry 60:9, pages 1085-1095.
Crossref
Rüdiger Hardeland. (2021) Divergent Importance of Chronobiological Considerations in High- and Low-dose Melatonin Therapies. Diseases 9:1, pages 18.
Crossref
Jonathan Emens, Elizabeth Rachel Super & Jillian N. Sanford. 2021. Pediatric Sleep Medicine. Pediatric Sleep Medicine
403
413
.
Phyllis C. Zee & Sabra M. Abbott. (2020) Circadian Rhythm Sleep-Wake Disorders. CONTINUUM: Lifelong Learning in Neurology 26:4, pages 988-1002.
Crossref
Helen J. Burgess & Jonathan S. Emens. (2020) Drugs Used in Circadian Sleep-Wake Rhythm Disturbances. Sleep Medicine Clinics 15:2, pages 301-310.
Crossref
Michael R. Gorman. (2020) Temporal organization of pineal melatonin signaling in mammals. Molecular and Cellular Endocrinology 503, pages 110687.
Crossref
Jonathan Emens. 2020. Circadian Rhythm Sleep-Wake Disorders. Circadian Rhythm Sleep-Wake Disorders
123
136
.
Sabra M. Abbott. (2019) Non–24-hour Sleep-Wake Rhythm Disorder. Neurologic Clinics 37:3, pages 545-552.
Crossref
Ann C. M. Smith, Rebecca S. Morse, Wendy Introne & Wallace C. DuncanJrJr. (2019) Twenty‐four‐hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith–Magenis syndrome, a neurodevelopmental disorder. American Journal of Medical Genetics Part A 179:2, pages 224-236.
Crossref
Yumna Saeed, Phyllis C. Zee & Sabra M. Abbott. 2019. Clinical Neurophysiology: Diseases and Disorders. Clinical Neurophysiology: Diseases and Disorders
369
380
.
Roberta M. Leu. 2019. Sleep in Children with Neurodevelopmental Disabilities. Sleep in Children with Neurodevelopmental Disabilities
339
350
.
Helen J. Burgess & Jonathan S. Emens. (2018) Drugs Used in Circadian Sleep-Wake Rhythm Disturbances. Sleep Medicine Clinics 13:2, pages 231-241.
Crossref
Rüdiger Hardeland. (2017) Melatonergic Sleep Promotion: Fundamental Chronobiological Issues Concerning Sleep Onset and Maintenance, Dose and Duration of Action. Sleep and Vigilance 2:1, pages 5-11.
Crossref
Gregory M. Brown, Roger S. McIntyre, Joshua Rosenblat & Rüdiger Hardeland. (2018) Depressive disorders: Processes leading to neurogeneration and potential novel treatments. Progress in Neuro-Psychopharmacology and Biological Psychiatry 80, pages 189-204.
Crossref
Maria Antonia Quera Salva, Sarah Hartley, Damien Léger & Yves A. Dauvilliers. (2017) Non-24-Hour Sleep–Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management. Frontiers in Neurology 8.
Crossref
Jonathan S. Emens & Charmane I. Eastman. (2017) Diagnosis and Treatment of Non-24-h Sleep–Wake Disorder in the Blind. Drugs 77:6, pages 637-650.
Crossref
A.J. Lewy. 2017. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Wallace C. DuncanJr.Jr., Elizabeth D. Ballard & Carlos A. Zarate. 2019. Sleep-Wake Neurobiology and Pharmacology. Sleep-Wake Neurobiology and Pharmacology
337
358
.
Bożena Muszyńska, Katarzyna Kała, Katarzyna Sułkowska-Ziaja, Agata Krakowska & Włodzimierz Opoka. (2016) Agaricus bisporus and its in vitro culture as a source of indole compounds released into artificial digestive juices. Food Chemistry 199, pages 509-515.
Crossref
Jonathan S. Emens & Helen J. Burgess. (2015) Effect of Light and Melatonin and Other Melatonin Receptor Agonists on Human Circadian Physiology. Sleep Medicine Clinics 10:4, pages 435-453.
Crossref
Sameer Gupta & Chandana Haldar. (2014) Nycthemeral variation in melatonin receptor expression in the lymphoid organs of a tropical seasonal breeder Funambulus pennanti. Journal of Comparative Physiology A 200:12, pages 1045-1055.
Crossref
Henry Keijzer, Marcel G. Smits, Jeanne F. Duffy & Leopold M.G. Curfs. (2014) Why the dim light melatonin onset (DLMO) should be measured before treatment of patients with circadian rhythm sleep disorders. Sleep Medicine Reviews 18:4, pages 333-339.
Crossref
Esmée M. S. Vural, Barbara C. van Munster & Sophia E. de Rooij. (2014) Optimal Dosages for Melatonin Supplementation Therapy in Older Adults: A Systematic Review of Current Literature. Drugs & Aging 31:6, pages 441-451.
Crossref
Jonathan S. Emens, Amber L. Laurie, Jeannie B. Songer & Alfred J. Lewy. (2013) Non-24-Hour Disorder in Blind Individuals Revisited: Variability and the Influence of Environmental Time Cues. Sleep 36:7, pages 1091-1100.
Crossref
A.J. Lewy. 2013. Encyclopedia of Sleep. Encyclopedia of Sleep
126
137
.
Thomas Roth. (2012) Appropriate therapeutic selection for patients with shift work disorder. Sleep Medicine 13:4, pages 335-341.
Crossref
Madeleine M. Grigg-Damberger. 2012. Therapy in Sleep Medicine. Therapy in Sleep Medicine
519
538
.
Sylvie Stacy. (2011) Relaxation Drinks and Their Use in Adolescents. Journal of Child and Adolescent Psychopharmacology 21:6, pages 605-610.
Crossref
Guy R. Warman, Matthew D. M. Pawley, Catherine Bolton, James F. Cheeseman, Antonio T. Fernando, Josephine Arendt & Anna Wirz-Justice. (2011) Circadian-Related Sleep Disorders and Sleep Medication Use in the New Zealand Blind Population: An Observational Prevalence Survey. PLoS ONE 6:7, pages e22073.
Crossref
Ingeborg M. van Geijlswijk, Hubert P. L. M. Korzilius & Marcel G. Smits. (2010) The Use of Exogenous Melatonin in Delayed Sleep Phase Disorder: A Meta-analysis. Sleep 33:12, pages 1605-1614.
Crossref
Ehren R. Dodson & Phyllis C. Zee. (2010) Therapeutics for Circadian Rhythm Sleep Disorders. Sleep Medicine Clinics 5:4, pages 701-715.
Crossref
Alfred Lewy. (2010) Clinical Implications of the Melatonin Phase Response Curve. The Journal of Clinical Endocrinology & Metabolism 95:7, pages 3158-3160.
Crossref
W. Braam, I. Van Geijlswijk, Henry Keijzer, Marcel G. Smits, Robert Didden & Leopold M. G. Curfs. (2010) Loss of response to melatonin treatment is associated with slow melatonin metabolism. Journal of Intellectual Disability Research 54:6, pages 547-555.
Crossref
Phyllis C. Zee, Sherry Wang-Weigand, Kenneth P. WrightJr.Jr., Xuejun Peng & Thomas Roth. (2010) Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel. Sleep Medicine 11:6, pages 525-533.
Crossref
Robert L Sack. 2010. Insomnia. Insomnia
181
198
.
Lia R. A. Bittencourt, Rogerio Santos-Silva, Marco T. De Mello, Monica L. Andersen & Sergio Tufik. (2009) Chronobiological Disorders: Current and Prevalent Conditions. Journal of Occupational Rehabilitation 20:1, pages 21-32.
Crossref
Michel A. Paul, James C. Miller, Gary W. Gray, Ryan J. Love, Harris R. Lieberman & Josephine Arendt. (2009) Melatonin treatment for eastward and westward travel preparation. Psychopharmacology 208:3, pages 377-386.
Crossref
Shantha M.W. Rajaratnam, Daniel A. Cohen & Naomi L. Rogers. (2009) Melatonin and Melatonin Analogues. Sleep Medicine Clinics 4:2, pages 179-193.
Crossref
Alfred J. Lewy, Jonathan S. Emens, Jeannie B. Songer, Neelam Sims, Amber L. Laurie, Steven C. Fiala & Allie Buti. (2009) Winter Depression: Integrating Mood, Circadian Rhythms, and the Sleep/Wake and Light/Dark Cycles into a Bio-Psycho-Social-Environmental Model. Sleep Medicine Clinics 4:2, pages 285-299.
Crossref
Robert L. Sack. (2009) The pathophysiology of jet lag. Travel Medicine and Infectious Disease 7:2, pages 102-110.
Crossref
A.J. Lewy, J. Emens, J. Songer & J. Rough. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
2505
2528
.
Robert Sack. 2008. Handbook of Sleep Disorders, Second Edition. Handbook of Sleep Disorders, Second Edition
191
205
.
Helen J. Burgess, Victoria L. Revell & Charmane I. Eastman. (2008) A three pulse phase response curve to three milligrams of melatonin in humans. The Journal of Physiology 586:2, pages 639-647.
Crossref
Alfred J. Lewy. (2007) Current Understanding and Future Implications of the Circadian Uses of Melatonin, a Neurohormone Discovered by Aaron B. Lerner. Journal of Investigative Dermatology 127:9, pages 2082-2085.
Crossref
Antonio Vela-Bueno, Sara Olavarrieta-Bernardino, Julio Fernández-Mendoza & Acacia Aguirre-Berrocal. (2007) Melatonin, Sleep, and Sleep Disorders. Sleep Medicine Clinics 2:2, pages 303-312.
Crossref
A. J. Lewy. (2007) Melatonin and Human Chronobiology. Cold Spring Harbor Symposia on Quantitative Biology 72:1, pages 623-636.
Crossref
Daniel F Kripke, Lawrence E Kline, Farhad F Shadan, Arthur Dawson, J Steven Poceta & Jeffrey A Elliott. (2006) Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262. BMC Women's Health 6:1.
Crossref
. 2006. Introducing Biological Rhythms. Introducing Biological Rhythms
426
525
.
Jonathan S. Emens & Alfred J. Lewy. 2005. Neuroendocrine Correlates of Sleep/Wakefulness. Neuroendocrine Correlates of Sleep/Wakefulness
311
323
.
Irina V. Zhdanova. (2005) Melatonin as a hypnotic: Pro. Sleep Medicine Reviews 9:1, pages 51-65.
Crossref
Sylvie Tordjman, George M. Anderson, Nadège Pichard, Henriette Charbuy & Yvan Touitou. (2005) Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biological Psychiatry 57:2, pages 134-138.
Crossref
Frank A. Scheer, Christian Cajochen, Fred W. Turek & Charles A. Czeisler. 2005. Principles and Practice of Sleep Medicine. Principles and Practice of Sleep Medicine
395
404
.
Matthew J. Gerdin, Monica I. Masana, MoiséS A. Rivera-Bermúdez, Randall L. Hudson, David J. Earnest, Martha U. Gillette & Margarita L. Dubocovich. (2004)
Melatonin desensitizes endogenous MT
2
melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin
. The FASEB Journal 18:14, pages 1646-1656.
Crossref
M. E. J. Wise. (2018) Melatonin use in children. Psychiatric Bulletin 28:9, pages 343-343.
Crossref
Alfred J. LewyJonathan S. Emens, Rebecca A. Bernert & Bryan J. Lefler. (2016) Eventual Entrainment of the Human Circadian Pacemaker by Melatonin is Independent of the Circadian Phase of Treatment Initiation: Clinical Implications. Journal of Biological Rhythms 19:1, pages 68-75.
Crossref
Lisa M. Hack, Steven W. Lockley, Josephine Arendt & Debra J. Skene. (2016) The Effects of Low-Dose 0.5-mg Melatonin on the Free-Running Circadian Rhythms of Blind Subjects. Journal of Biological Rhythms 18:5, pages 420-429.
Crossref